Exelixis
EXEL
#1822
Rank
โ‚น1.075 T
Marketcap
โ‚น4,234
Share price
-2.41%
Change (1 day)
33.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company